CADENCE PHARMACEUTICALS INC's ticker is CADX and the CUSIP is 12738T100. A total of 77 filers reported holding CADENCE PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 4.64 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FALCON POINT CAPITAL, LLC | 113,808 | $717,000 | 0.76% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 1,700,000 | $10,711,000 | 0.64% |
| NEA Management Company, LLC | 2,070,286 | $13,043,000 | 0.52% |
| WALL STREET ASSOCIATES | 460,000 | $2,898,000 | 0.27% |
| CR Intrinsic Investors, LLC | 764,922 | $4,827,000 | 0.15% |
| Coe Capital Management, LLC | 20,000 | $126,000 | 0.08% |
| A.R.T. Advisors, LLC | 123,399 | $777,000 | 0.04% |
| ELLINGTON MANAGEMENT GROUP LLC | 19,000 | $120,000 | 0.02% |
| Quotient Investors, LLC | 10,900 | $69,000 | 0.02% |
| MASON STREET ADVISORS, LLC | 249,600 | $1,575,000 | 0.02% |